sodium nitroprusside
NDC 14335-131, sodium nitroprusside, injection, solution, concentrate, from Hainan Poly Pharm. Co., Ltd..
- Product NDC
- 14335-131
- Status
- Listed
- Labeler
- Hainan Poly Pharm. Co., Ltd.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214199
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/14335-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM NITROPRUSSIDE50 mg/2mL
Pharmacologic classes
Vasodilation [PE]; Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 14335-131-01 | 14335013101 | 1 VIAL in 1 CARTON (14335-131-01) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1f875445-f8e4-b097-e063-6294a90ad544
Use it
Look up 14335-131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/14335-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 14335-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.